MNTA’s CEO says M230 is the most exciting compound in the company’s pipeline; this PR (from Nov 2016) explains what it is: http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=999935 (The post this message replies to contained an expired link from Yahoo.)